Quantifying Heterogeneity in Tumors: Proposing a New Method Utilizing Convolutional Neuronal Networks

Georg Prokop, Michael Örtl, Marina Fotteler, Peter Schüffler, Johannes Schobel, Walter Swoboda, Jürgen Schlegel, Friederike Liesche-Starnecker

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

2 Scopus citations

Abstract

Heterogeneity is a hallmark of glioblastoma (GBM), the most common malignant brain tumor, and a key reason for the poor survival rate of patients. However, establishing a clinically applicable, cost-efficient tool to measure and quantify heterogeneity is challenging. We present a novel method in an ongoing study utilizing two convolutional neuronal networks (CNN). After digitizing tumor samples, the first CNN delimitates GBM from normal tissue, the second quantifies heterogeneity within the tumor. Since neuronal networks can detect and interpret underlying and hidden information within images and have the ability to incorporate different information sets (i.e. clinical data and mutational status), this approach might venture towards a next level of integrated diagnosis. It may be applicable to other tumors as well and lead to a more precision-based medicine.

Original languageEnglish
Title of host publicationInformatics and Technology in Clinical Care and Public Health
EditorsJohn Mantas, Arie Hasman, Mowafa S. Househ, Parisis Gallos, Emmanouil Zoulias, Joseph Liasko
PublisherIOS Press BV
Pages397-400
Number of pages4
ISBN (Electronic)9781643682501
DOIs
StatePublished - 2022

Publication series

NameStudies in Health Technology and Informatics
Volume289
ISSN (Print)0926-9630
ISSN (Electronic)1879-8365

Keywords

  • Convolutional Neuronal Network
  • Digital Pathology
  • Glioblastoma
  • Neuropathology
  • Tumor heterogeneity

Fingerprint

Dive into the research topics of 'Quantifying Heterogeneity in Tumors: Proposing a New Method Utilizing Convolutional Neuronal Networks'. Together they form a unique fingerprint.

Cite this